Reduced angiopoietin-2 as a predictive biomarker for clomiphene citrate resistance in polycystic ovary syndrome
Background: Even though angiopoeitin-2 and interleukin (IL)-23 are known to be altered in polycystic ovary syndrome (PCOS), their association with clomiphene citrate (CC) resistance has not been studied. Aim: The objective of the study was to investigate whether angiopoietin-2 levels are associated...
Main Authors: | Luxmipratha Rajendiran, Hanumanthappa Nandeesha, Thyagaraju Chitra |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2021-01-01
|
Series: | Journal of Human Reproductive Sciences |
Subjects: | |
Online Access: | http://www.jhrsonline.org/article.asp?issn=0974-1208;year=2021;volume=14;issue=2;spage=144;epage=148;aulast=Rajendiran |
Similar Items
-
Metformin-clomiphene citrate vs. clomiphene citrate alone: Polycystic ovarian syndrome
by: Aqueela Ayaz, et al.
Published: (2013-01-01) -
Usefulness of intermittent clomiphene citrate treatment for women with polycystic ovarian syndrome that is resistant to standard clomiphene citrate treatment
by: Akihisa Takasaki, et al.
Published: (2018-10-01) -
Pharmacokinetics Characteristics of Clomiphene Citrate in Patients with Polycystic Ovary Syndrome (PCOS)
by: N Mirhosseini,, et al.
Published: (2011-11-01) -
Comparing the effect of gonadotropin versus letrozole for induction of ovulation in patients with polycystic ovary syndrome with clomiphene citrate failure
by: Ahmed I.A Ali, et al.
Published: (2022-01-01) -
Comparison of the Effects of Letrozole and Clomiphene Citrate on Ovulation and Pregnancy Rate in Patients with Polycystic Ovary Syndrome
by: Sedigheh Dehbashi, et al.
Published: (2009-03-01)